GlassScriptPhysician profile
Karen Appiah
NPI 1427390434
$559.54
in general payments reported to CMS, 2019-2025
12 companies · $63.43 in 2025
The $63.43 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.41 · 2020: $149 · 2021: $136 · 2022: $12.41 · 2023: $89.92 · 2024: $48.55 · 2025: $63.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $273.56 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $43.49 | 2020 | |
| Aimmune Therapeutics, INC. | $42.86 | 2023 | |
| Pfizer INC. | $34.70 | 2024-2025 | |
| Mylan Specialty L.P. | $32.15 | 2019-2022 | |
| Abbvie INC. | $30.72 | 2024 | |
| Philips North America LLC | $23.67 | 2025 | Vest Therapy Und |
| Gilead Sciences, INC. | $22.89 | 2025 | Veklury |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.58 | 2020 | |
| Cook Medical LLC | $13.13 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.06 | 2023 | Gattex |
| Novartis Pharmaceuticals Corporation | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Appiah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.